Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...

PHILADELPHIA, PA—Etripamil nasal spray (Milestone Pharmaceuticals) appears to provide quick relief for patients with atrial fibrillation (AF) accompanied by a rapid ventricular rate, according to ...

Please provide your email address to receive an email when new articles are posted on . Etripamil reduced ventricular rate in patients with atrial fibrillation and rapid ventricular rate compared with ...

The PDUFA date for CARDAMYST™ is set for March 27, 2025, indicating a lengthy approval timeline that could delay commercialization and revenue generation for the company. The reliance on the FDA's ...

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib) - an irregular, fast heartbeat that is ...

The lead-I electrocardiogram (ECG) devices were assessed when they were used in addition to 12‑lead ECGs. Clinical experts advised that a 12‑lead ECG would still be used after lead-I ECGs to identify ...